These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 34906538)

  • 1. Short- and long-term cardiovascular outcomes in insulin-treated versus non-insulin-treated diabetes mellitus patients after percutaneous coronary intervention: A systematic review and meta-analysis.
    Hassan W; Saquib J; Khatri M; Kazmi SK; Kotak S; Hassan H; Ahmed J
    Indian Heart J; 2022; 74(1):13-21. PubMed ID: 34906538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients.
    Zhuo X; Zhang C; Feng J; Ouyang S; Niu P; Dai Z
    Medicine (Baltimore); 2019 Feb; 98(8):e14669. PubMed ID: 30813214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis.
    Bundhun PK; Li N; Chen MH
    Cardiovasc Diabetol; 2015 Oct; 14():135. PubMed ID: 26446829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.
    Li N; Yang YG; Chen MH
    BMC Cardiovasc Disord; 2016 Nov; 16(1):238. PubMed ID: 27887590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cardiovascular outcomes of biodegradable polymer drug eluting stents in patients with diabetes versus non-diabetes mellitus: a meta-analysis.
    Wang H; Zu Q; Tang H; Lu M; Chen R; Yang Z
    Cardiovasc Diabetol; 2023 Aug; 22(1):228. PubMed ID: 37644465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Siddiqi TJ; Khan MS; Karimi Galougahi K; Shlofmitz E; Moses JW; Rao S; West NEJ; Wolff E; Hochler J; Chau K; Khalique O; Shlofmitz RA; Jeremias A; Ali ZA
    Catheter Cardiovasc Interv; 2022 Nov; 100 Suppl 1():S44-S56. PubMed ID: 36251325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis.
    Ge Y; He D; Shao Y; Wang L; Yan W
    Ann Noninvasive Electrocardiol; 2022 Sep; 27(5):e12953. PubMed ID: 35467783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
    Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
    J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: Meta-analysis of randomized trials.
    Bavishi C; Sardar P; Chatterjee S; Khan AR; Shah A; Ather S; Lemos PA; Moreno P; Stone GW
    Am Heart J; 2017 Mar; 185():26-34. PubMed ID: 28267472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
    Lee CH; Choi SW; Jun SW; Hwang J; Kim IC; Cho YK; Park HS; Yoon HJ; Kim H; Nam CW; Han S; Kim KB; Hur SH
    PLoS One; 2020; 15(6):e0234362. PubMed ID: 32520973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sharma A; Garg A; Elmariah S; Drachman D; Obiagwu C; Vallakati A; Sharma SK; Lavie CJ; Mukherjee D; Waksman R; Stefanini GG; Feres F; Marmur JD; Helft G
    Prog Cardiovasc Dis; 2018; 60(4-5):500-507. PubMed ID: 29277295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Wu ZJ; Chen MH
    Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of chronic total occlusion treated by successful percutaneous coronary intervention in patients with or without diabetes mellitus: a systematic review and meta-analysis.
    Zhu Y; Meng S; Chen M; Liu K; Jia R; Li H; Zhu H; Jin Z
    Cardiovasc Diabetol; 2021 Jan; 20(1):29. PubMed ID: 33516214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crush versus Culotte stenting techniques for coronary bifurcation lesions: A systematic review and meta-analysis of clinical trials with long-term follow-up.
    Chen E; Cai W; Chen LL
    Medicine (Baltimore); 2019 Apr; 98(14):e14865. PubMed ID: 30946314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study.
    Hommels TM; Hermanides RS; Rasoul S; Berta B; IJsselmuiden AJJ; Jessurun GAJ; Benit E; Pereira B; De Luca G; Kedhi E
    Cardiovasc Diabetol; 2019 Mar; 18(1):25. PubMed ID: 30851731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.
    Lu H; Tang B; Zhou Y; Xu C; Bundhun PK; Tang Z; Bao H
    Diabetes Ther; 2019 Aug; 10(4):1487-1497. PubMed ID: 31256352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Analysis Comparing Outcomes With Bifurcation Percutaneous Coronary Intervention Techniques.
    Elbadawi A; Shnoda M; Dang A; Gad M; Abdelazeem M; Saad M; Salama A; Sharma A; Gilani S; Latib A; Rab T; Elgendy IY; Abbott JD
    Am J Cardiol; 2022 Feb; 165():37-45. PubMed ID: 34937656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.